FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to ophthalmology. A drug preparation stimulates proliferation of epithelial cells of a tarsal gland or epithelial cells of a cornea. The drug preparation contains [3-[2-[4-isopropyl-2-(4-triflouromethyl)phenyl-5-thiazolyl]ethyl]-5-methyl-1,2-benzisoxazol-6-yl]oxyacetic acid, [4-[3-[2-(4-triflouromethyl)phenyl-4-isopropyl-5-thiazolyl]propionyl]-2-methylphenoxy]acetic acid or [4-[3-[2-(2-hydroxy-4-chloriophenyl)-5-isopropyl-4-oxazolyl]propionyl]-2-methylphenoxy] acetic acid, or their pharmaceutically acceptable salt as an active ingredient. Said active ingredient is applied for making the drug preparation, and as stimulating proliferation of epithelial cells of the tarsal gland or epithelial cells of the cornea.
EFFECT: group of inventions provides treating eye diseases, such as xerophthalmus, tarsal gland dysfunction, corneal epithelial diseases.
18 cl, 3 dwg, 4 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STABLE AQUEOUS SOLUTION | 2014 |
|
RU2665639C2 |
| CLEAR AQUEOUS SOLUTION | 2014 |
|
RU2662067C2 |
| ACTIVATING AGENT FOR RECEPTOR ACTIVATED BY PEROXISOME GROWTH-STIMULATING AGENTS | 2009 |
|
RU2501794C2 |
| PROPHYLACTIC AND THERAPEUTIC DRUG FOR AGE-RELATED MACULAR DEGENERATION | 2008 |
|
RU2460526C2 |
| THERAPEUTIC AGENT (Y-39983) FOR CORNEAL ENDOTHELIAL DYSFUNCTION | 2010 |
|
RU2563141C2 |
| PHENYLACETIC ACID DERIVATIVE AND ITS USE | 2004 |
|
RU2349587C2 |
| PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR δ ACTIVATING AGENT | 2007 |
|
RU2435764C2 |
| CULTURE MEDIUM FOR EPITHELIAL CELLS OF ESOPHAGEAL SQUAMOUS CELL CARCINOMA, METHOD OF CULTIVATION AND USE THEREOF | 2020 |
|
RU2816529C1 |
| AGENT FOR ENHANCING CORNEAL EPITHELIAL BARRIER FUNCTION | 2009 |
|
RU2484848C2 |
| (R)-2-METHYL-PIPERAZINE DERIVATIVES AS MODULATORS OF CXCR3 RECEPTOR | 2016 |
|
RU2706232C2 |
